$6.2-million settlement reached in British Columbia class action against GlaxoSmithKline - (Vancouver Sun via NewsPoints Desk)

  • GlaxoSmithKline has agreed to pay $6.2 million to settle a class-action lawsuit against the drugmaker in British Columbia regarding alleged birth defects caused by the antidepressant Paxil, as reported Vancouver Sun Wednesday.

  • The drugmaker did not admit to wrongdoing or liability under the agreed terms.

  • GlaxoSmithKline indicated that it reached a settlement "to avoid the time and expense associated with the trial and the subsequent steps in the class-action proceeding."

  • "We continue to be of the view that the scientific evidence does not establish that exposure to Paxil during pregnancy causes cardiovascular birth defects," the drugmaker contended.

  • As many as 200 children could be covered under the settlement.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.